KMTS Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) is expected to report earnings on September 14, 2026, after the market close. The consensus earnings estimate is a loss of $0.61 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.3% since its last earnings release on July 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
Sector
Healthcare
Industry
Medical Appliances/Equipment